| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698341 | Clinical Oncology | 2017 | 10 Pages |
Abstract
ACT use varies across age groups and geographic regions. ACT is not associated with improved survival among patients with stage II colon cancer including those with high-risk disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.M. Booth, S. Nanji, X. Wei, Y. Peng, J.J. Biagi, T.P. Hanna, M.K. Krzyzanowska, W.J. Mackillop,